PMID- 21468743 OWN - NLM STAT- MEDLINE DCOM- 20111004 LR - 20211020 IS - 1432-1041 (Electronic) IS - 0031-6970 (Linking) VI - 67 IP - 7 DP - 2011 Jul TI - Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM). PG - 653-61 LID - 10.1007/s00228-011-1038-z [doi] AB - The urgent need to treat type 2 diabetes mellitus (T2DM), which is currently reaching epidemic proportions, has been a major focus of healthcare systems and policy makers worldwide. Pharmacological treatment and lifestyle interventions together with the control of cardiovascular risk factors are the main strategies to prevent or delay the onset of T2DM. The present review discusses the state of the art knowledge of effective therapeutic approaches (metformin, thiazolidinediones, nateglinides, alpha-glucosidase inhibitors, incretin-based and angiotensin-based therapies, weight reducers, statins, fibric acid derivatives), including surgery, and identifies the major lifestyle changes for specific target groups. FAU - Souto, Selma B AU - Souto SB AD - Department of Endocrinology, Hospital de Sao Joao, Alameda Prof. Hernani Monteiro, 4200-319, Porto, Portugal. sbsouto.md@gmail.com FAU - Souto, Eliana B AU - Souto EB FAU - Braga, Daniel C AU - Braga DC FAU - Medina, Jose L AU - Medina JL LA - eng PT - Journal Article PT - Review DEP - 20110406 PL - Germany TA - Eur J Clin Pharmacol JT - European journal of clinical pharmacology JID - 1256165 RN - 0 (Hypoglycemic Agents) SB - IM MH - Diabetes Mellitus, Type 2/*prevention & control MH - Humans MH - Hypoglycemic Agents/therapeutic use EDAT- 2011/04/07 06:00 MHDA- 2011/10/05 06:00 CRDT- 2011/04/07 06:00 PHST- 2010/12/24 00:00 [received] PHST- 2011/03/15 00:00 [accepted] PHST- 2011/04/07 06:00 [entrez] PHST- 2011/04/07 06:00 [pubmed] PHST- 2011/10/05 06:00 [medline] AID - 10.1007/s00228-011-1038-z [doi] PST - ppublish SO - Eur J Clin Pharmacol. 2011 Jul;67(7):653-61. doi: 10.1007/s00228-011-1038-z. Epub 2011 Apr 6.